
Late-breaking EADV 2026 data showed significant improvements in skin clearance, itch, pain, and patient satisfaction among patients treated with lebrikizumab.
Patients who undergo a solid organ transplant procedure have an alarmingly higher incidence of skin cancers compared to the general population. Special care and management strategies involving a multidisciplinary approach are warranted in this group, says Mich?l O'Donoghue, M.D., a dermatologist in private practice in Oak Brook, Ill.






